Peak Bio, Inc. Proceeds from Stock Options Exercised
Peak Bio, Inc. reported Proceeds from Stock Options Exercised of $0 for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2024-11-12
- Peak Bio, Inc. proceeds from stock options exercised for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- Peak Bio, Inc. proceeds from stock options exercised for the quarter ending 2023-12-31 was $4.92K.
- Peak Bio, Inc. proceeds from stock options exercised for the quarter ending 2023-09-30 was $625.00K.
- Peak Bio, Inc. proceeds from stock options exercised for the quarter ending 2022-12-31 was $0.00.
- Peak Bio, Inc. proceeds from stock options exercised for fiscal 2023 was $1.03M.
- Peak Bio, Inc. proceeds from stock options exercised for fiscal 2022 was $0.00.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-23 | |||
| 2023-12-31 | $4.92K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-06 | $629.92K derived: sum of 2 quarters · filed 2024-11-12 | $1.03M 10-K · filed 2024-08-06 | |
| 2023-09-30 | $625.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.02M 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $400.00K 10-Q · filed 2024-08-23 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-06 | $0.00 10-K · filed 2024-08-06 | ||
| 2022-09-30 | $0.00 10-Q · filed 2024-06-25 |